NCM · Financial Statements

BCAB (BCAB) Financial Statements

$1.74 NCM: BCAB Market Cap $2.88M

BCAB most recently reported annual revenue of $2.0M, a net loss of $60.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

BCAB: Revenue fell from $11.0M in 2018 to $2.0M in 2025, a change of -81.8% over 7 years; net profit was positive in 0 of 8 reported years; operating margin moved from -265.7% to -2965.3%, a shift of -2699.6 percentage points; the most recent year shows a net loss of $60.0M.

Income Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Revenue$11.0M$5.0M$0$0$0$0$11.0M$2.0M
Operating Expenses$39.0M$33.0M$31.0M$97.0M$108.0M$130.0M$85.0M$61.0M
Operating Profit$-28.0M$-28.0M$-30.0M$-96.0M$-108.0M$-130.0M$-74.0M$-59.0M
Operating Margin-265.7%-543.6%-7016.1%-38576.0%0.0%0.0%-672.2%-2965.3%
Other Income$-1.0M$-2.0M$-6.0M$1.0M$2.0M$6.0M$4.0M$0
Interest$1.0M$2.0M$1.0M$0$0$0$0$0
Depreciation$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$0
Profit Before Tax$-29.0M$-30.0M$-36.0M$-95.0M$-106.0M$-123.0M$-70.0M$-60.0M
Tax$-700,000$0$0$0$0$0$0$0
Net Profit$-29.0M$-30.0M$-36.0M$-95.0M$-105.0M$-123.0M$-70.0M$-60.0M
EPS$-67.00$-46.50$-53.00$-138.00$-137.00$-129.00$-72.00$-50.50
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$0$0$0$0$11.0M$0$0$0$0$2.0M$0$7.0M
Operating Expenses$35.0M$29.0M$24.0M$22.0M$22.0M$16.0M$18.0M$19.0M$14.0M$11.0M$9.0M$6.0M
Operating Profit$-35.0M$-29.0M$-24.0M$-22.0M$-11.0M$-16.0M$-18.0M$-19.0M$-14.0M$-9.0M$-9.0M$0
Operating Margin0.0%0.0%0.0%0.0%-102.5%0.0%0.0%0.0%0.0%-462.8%0.0%3.5%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-33.0M$-27.0M$-23.0M$-21.0M$-11.0M$-15.0M$-15.0M$-19.0M$-16.0M$-10.0M$-6.0M$0
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-33.0M$-27.0M$-23.0M$-21.0M$-11.0M$-15.0M$-15.0M$-19.0M$-16.0M$-10.0M$-6.0M$0
EPS$-35.00$-28.00$-24.00$-22.00$-11.00$-15.00$-13.00$-16.00$-13.50$-8.00$-4.22$0.27

Over the 8 years reported for BCAB, borrowings decreased from $15.0M in 2018 to $6.0M in 2025, cash stood at $7.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 0.36 times.

Balance Sheet — 8 Years (USD millions)

Metric20182019202020212022202320242025
Total Assets$17.0M$9.0M$245.0M$254.0M$226.0M$120.0M$52.0M$14.0M
Current Assets$13.0M$5.0M$241.0M$247.0M$220.0M$116.0M$51.0M$8.0M
Cash$11.0M$4.0M$239.0M$245.0M$216.0M$111.0M$49.0M$7.0M
Inventory$0$0$0$0$0$0$0$0
Receivables$0$0$0$0$0$0$0$0
Fixed Assets$4.0M$5.0M$4.0M$7.0M$5.0M$3.0M$1.0M$6.0M
Capital Work in Progress$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0
Total Liabilities$45.0M$65.0M$35.0M$44.0M$45.0M$49.0M$38.0M$50.0M
Current Liabilities$9.0M$27.0M$32.0M$20.0M$23.0M$28.0M$15.0M$22.0M
Borrowings$15.0M$18.0M$1.0M$5.0M$4.0M$2.0M$1.0M$6.0M
Other Liabilities$30.0M$47.0M$34.0M$38.0M$41.0M$47.0M$37.0M$44.0M
Equity$1.0M$1.0M$0$0$0$0$0$0
Reserves$-28.0M$-56.0M$210.0M$211.0M$180.0M$71.0M$14.0M$-36.0M

For BCAB, operating cash flow was positive in 0 of 8 reported years; free cash flow in the latest year was negative at $48.0M; free cash flow was positive in 0 of 8 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Operating Cash Flow$-35.0M$-10.0M$-36.0M$-62.0M$-90.0M$-104.0M$-72.0M$-48.0M
Investing Cash Flow$-2.0M$-3.0M$-1.0M$-2.0M$-1.0M$0$0$0
Financing Cash Flow$0$0$0$-2.0M$0$0$0$-1.0M
Net Cash Flow$-31.0M$-7.0M$235.0M$6.0M$-29.0M$-104.0M$-62.0M$-42.0M
Free Cash Flow$-36.0M$-11.0M$-37.0M$-63.0M$-91.0M$-104.0M$-72.0M$-48.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.33
FCF Yield-453.51%
Quick Ratio0.20
Interest Coverage—
Return 1Y-78.38%
Return 3Y-96.84%
Return 5Y-99.78%

BCAB (BCAB) financials — frequently asked questions

What is BCAB's annual revenue?

BCAB reported annual revenue of $2.0M in its most recent fiscal year.

What is BCAB's net profit?

BCAB reported a net loss of $60.0M in its most recent fiscal year.

What is BCAB EV/EBITDA?

BCAB's enterprise value to EBITDA (EV/EBITDA) ratio is -0.33. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
BCAB Overview BCAB Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.